Trivarx Ltd has released a press release.
Receipt of R&D Tax Incentive Refund
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from TrivarX
- Medibio Releases Corporate Health Product, ilumen
- Notice Received Under Section 249D of the Corporations Act
- Executive Leadership Changes
- Clinical Study Shows Improvement to Diagnostic Standard
- Preliminary Final Report
Later from TrivarX
- MEB Signs ilumen Contract with Large Australian Employer
- Medibio Appoints CEO and Managing Director
- Medibio Provides Update on FDA Process
- Response to ASX Appendix 4C Query
- Exclusive Agreement Signed for ilumen Pilot Program
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX